Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

BACKGROUND: In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated metastatic colorectal cancer (mCRC). PRECONNECT was designed to further characterise safety and clinical use of trifluridine/tipira...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachet, Jean-Baptiste, Wyrwicz, Lucjan, Price, Timothy, Cremolini, Chiara, Phelip, Jean-Marc, Portales, Fabienne, Ozet, Ahmet, Cicin, Irfan, Atlan, Dan, Becquart, Martin, Vidot, Loick, Mounedji, Nadjat, Van Cutsem, Eric, Taieb, Julien, Falcone, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264999/
https://www.ncbi.nlm.nih.gov/pubmed/32487542
http://dx.doi.org/10.1136/esmoopen-2020-000698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264999/
https://www.ncbi.nlm.nih.gov/pubmed/32487542
http://dx.doi.org/10.1136/esmoopen-2020-000698

Ejemplares similares